The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Nanocarriers Market By The End Of 2030?

The nanocarriers market size has experienced rapid expansion over recent years. It is projected to grow from $11.61 billion in 2025 to $13.74 billion in 2026, achieving a compound annual growth rate (CAGR) of 18.4%. The historical growth of this market can be ascribed to several factors, including advancements in nanotechnology research, increasing pharmaceutical R&D investments, a growing need for improved drug bioavailability, the early adoption of nanoparticle-based therapeutics, and the expansion of academic and clinical research.

The nanocarriers market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $26.74 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 18.1%. This projected growth during the forecast period can be primarily attributed to several factors, including the escalating demand for personalized therapeutics, increased capital allocation towards advanced drug delivery systems, the broadening scope of nanocarrier applications within oncology and gene therapy, an intensifying emphasis on mitigating drug side effects, and continuous breakthroughs in nanoscale engineering. Key trends foreseen throughout this period encompass the accelerated creation of targeted drug delivery platforms, a surge in the utilization of lipid and polymeric nanocarriers, a heightened concentration on systems for controlled and sustained drug release, the extending use of nanocarriers in gene and vaccine delivery, and improved integration with precision medicine strategies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28275&type=smp

Which Market Drivers Are Supporting The Expansion Of The Nanocarriers Market?

The increasing need for personalized medicines is anticipated to boost the nanocarriers market. Personalized medicine involves customizing medical care for each patient using their genetic, biomarker, and molecular data. This approach is gaining traction because it enables physicians to customize cancer treatments according to a patient’s genetic makeup, thereby enhancing efficacy and minimizing unwanted side effects. Nanocarriers are crucial for personalized medicine as they facilitate precise drug delivery to specific patient targets, regulate release, improve drug absorption, and allow for customized combination therapies based on individual biological profiles. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the United States Food and Drug Administration (FDA) sanctioned 16 novel personalized treatments for rare diseases, a significant jump from just six approvals in 2022. Consequently, the escalating demand for personalized medicines is propelling the expansion of the nanocarriers market.

Which Segment Classifications Shape The Nanocarriers Market?

The nanocarriers market covered in this report is segmented –

1) By Type: Polymeric Nanocarriers, Lipid-Based Nanocarriers, Inorganic Nanocarriers, Other Types

2) By Application: Drug Delivery, Diagnostics, Vaccines, Gene Therapy, Other Applications

3) By End-User: Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Polymeric Nanocarriers: Nanoparticles Of Poly Lactic Acid, Nanoparticles Of Poly Lactic-Co-Glycolic Acid, Nanoparticles Of Chitosan, Nanoparticles Of Gelatin, Nanoparticles Of Polycaprolactone

2) By Lipid-Based Nanocarriers: Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, Liposomes, Nanoemulsions, Self-Emulsifying Drug Delivery Systems

3) By Inorganic Nanocarriers: Gold Nanoparticles, Silver Nanoparticles, Silica Nanoparticles, Magnetic Nanoparticles, Quantum Dots

4) By Other Types: Dendrimers, Protein-Based Nanocarriers, Carbon Nanotubes, Nanocrystals, Exosomes

How Are Trends Impacting The Nanocarriers Market?

Leading companies in the nanocarriers market are prioritizing the advancement of formulations, particularly lipid nanoparticle technologies, to improve targeted drug delivery and boost therapeutic effectiveness. Lipid nanoparticle technologies are microscopic, fat-based carriers designed to safely and efficiently transport drugs or genetic therapies to specific cells or tissues. For instance, in July 2023, Cytiva, a US-based biotechnology company, launched the NanoAssemblr commercial formulation system. This fully automated, single-use platform is engineered to facilitate end-to-end clinical and commercial manufacturing of lipid nanoparticle (LNP) medicines. The system utilizes Cytiva’s NxGen technology to deliver controlled, reproducible mixing, ensuring consistent quality from research through large-scale manufacturing under cGMP conditions. This platform mitigates cross-contamination risks with its single-use fluid path and supports efficient multi-product manufacturing within a single facility. It also incorporates intuitive software that adheres to regulatory standards, automating workflows and enabling electronic batch records, thus streamlining the production of genomic medicines like mRNA vaccines, gene therapies, and cancer vaccines.

Which Companies Are Expanding Their Footprint In The Nanocarriers Market?

Major companies operating in the nanocarriers market are F. Hoffmann-La Roche Ltd, Pfizer Inc., Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, Amgen Inc., Evonik Industries AG, Matinas BioPharma Holdings Inc., Luye Pharma Group Ltd., Ascendia Pharmaceuticals Inc., Arcturus Therapeutics Holdings Inc., Nanobiotix S.A., Polymun Scientific Immunbiologische Forschung GmbH, ReCode Therapeutics Inc., Celsion Corporation, Starpharma Holdings Limited, EnGeneIC Ltd., Acuitas Therapeutics Inc., Altamira Therapeutics Ltd., Nanexa AB

Read the full nanocarriers market report here:

https://www.thebusinessresearchcompany.com/report/nanocarriers-global-market-report

How Is The Nanocarriers Market Distributed Across Key Geographic Regions?

North America was the largest region in the nanocarriers market in 2025. The regions covered in the nanocarriers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Nanocarriers Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28275&type=smp

Browse Through More Reports Similar to the Global Nanocarriers Market 2026, By The Business Research Company

Microcarrier Market Report 2026

https://www.thebusinessresearchcompany.com/report/microcarrier-global-market-report

Nanomaterials Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanomaterials-global-market-report

Nanofibers Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanofibers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model